C
Celon Laboratories
Celon Laboratories Limited is a specialty-focused pharmaceutical company with core competencies in Oncology and Critical Care.
About Celon Laboratories
Celon Labs is a prominent player in the healthcare industry, specializing in the development and marketing of niche therapeutic products. The company focuses on creating high-quality, innovative solutions that address specific medical needs, particularly in areas that are often underserved by larger pharmaceutical companies. Celon Labs serves a diverse range of clients, including hospitals, clinics, and healthcare providers, primarily in the oncology and critical care segments. Operating in the specialty pharmaceuticals market, the company leverages its in-house research and development capabilities, along with its manufacturing and regulatory expertise, to bring a wide variety of products from the laboratory to the market. Celon Labs generates revenue through the sale of its specialty pharmaceutical products, which are designed to improve patient outcomes and enhance the quality of life. The company's business model is built on continuous innovation, operational flexibility, and a commitment to quality care.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2007
- Headquarters
- India
- Employees
- 582
- Open positions
- None listed
- Dealroom signal
- 37.4/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Nov 2020 | $0 | — | KELIX bio | — |
| LATE VC✓Equity / VC | Oct 2010 | $16M | $63M | Sequoia | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Celon Laboratories is 1K monthly website visits, up 108.3% over the last three months. Celon Laboratories's team grew 7.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Other known investors3 additional known investors
KELIX bio
Peak XV Partners
Vimal Kavuru
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Celon Laboratories on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Celon Laboratories’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.